维普中文期刊产品整合服务
218篇 您的检索式:作者名="Herrin"
    题名 作者 年代 出处 被引量
1Hepatocellular carcinoma after Iocoregional therapy:Magnetic resonance imaging findings in falsely negative exams显示文摘AIM:To elucidate causes for false negative magnetic resonance imaging(MRI)exams by identifying imaging characteristics that predict viable hepatocellular carcinoma(HCC)in lesions previously treated with locoregional therapy when obvious findings of recurrence are absent.METHODS:This retrospective institutional review board-approved and Health Insurance Portability and Accountability Act-compliant study included patients who underwent liver transplantation at our center between 1/1/2000 and 12/31/2012 after being treated for HCC with locoregional therapy.All selected patients had a contrast-enhanced MRI after locoregional therapy within 90 d of transplant that was prospectively interpreted as without evidence of residual or recurrenttumor.Retrospectively,2 radiologists,blinded to clinica and pathological data,independently reviewed the pre transplant MRIs for 7 imaging features.Liver explan histopathology provided the reference standard,with clinically significant tumor defined as viable tumor≥1.0cm in maximum dimension.Fisher’s exact test was firs performed to identify significant imaging features.RESULTS:Inclusion criteria selected for 42 patients with 65 treated lesions.Fourteen of 42 patients(33%and 16 of 65 treated lesions(25%)had clinically significant viable tumor on explant histology.None o the 7 imaging findings examined could reliably and reproducibly determine which treated lesion had viable tumor when the exam had been prospectively read as without evidence of viable HCC.CONCLUSION:After locoregional therapy some treated lesions that do not demonstrate any MRI evidence o HCC will contain viable tumor.As such even patients with a negative MRI following treatment should receive regular short-term imaging surveillance because some have occult viable tumor.The possibility of occult tumo should be a consideration when contemplating any action which might delay liver transplant.David Becker-Weidman Jesse M Civan Sandeep P Deshmukh Christopher G Roth Steven K Herrine Laurence Parker Donald G Mitchell 2016World Journal of Hepatology2016,8,16:2
2Antibody responses of variable lymphocyte receptors in the lamprey显示文摘Alder MN Herrin BR Sadlonova A 2008Nat Immunol2008,9,:1
3Justement trem like transcript 2 is expressed on cells of the myeloid/granuloid and B lymphoid lineage and is up-regulated in response to inflammation显示文摘Glenn-King R Brantley R Herrin H 2006J Immunol2006,176,:1
4Strategies for reducing the door-to-balloon time in acute myocardial infarction显示文摘Bradley EH Herrin J Wang Y 2006N Engl J Med2006,355,22:1
5Effect of door-to- balloon time on mortality in patients with ST-segment elevation myocardial infarction 显示文摘McNamara RL Wang Y Herrin J 2006J Am Coil Cardiol2006,47,11:1
6Hospital improvement in time to reperfusion in patients with acute myocardial infarction,1999 to 2002显示文摘McNamara RJ Herrin J Bradley EH 0,,:1
7Spontaneous rupture of an iliac vein显示文摘Herrin BJ Osborn P Diste A 1975Vasc Surg1975,9,:1
8Strategies for reducing the door- to- balloon time in acute myocardial infarction 显示文摘Bradley EH Herrin J Wang Y 2006N Engl J Med2006,355,22:1
9Xenon purity analysis for exo-200 via mass spectrometry 显示文摘Dobi A Hall C Slutsky S Yen Y R Aharmin B Auger M Barbeau P S Benitez-Medina C Breidenbach M Cleveland B Conley R Cook J Cook S Counts I Craddock W Daniels T Davis C G Davis J Devoe R Dixit M Dolinski M J Donato K Fairbank Jr W Farine J Fierlinger P Franco D Giroux G Gornea R Graham K Gratta G Green C Hagemann C Hall K Hallman D Hargrove C Herrin S Hughes M Hodgson J Juget F Karelin A Kaufman L J Kuchenkov A Kumar K Leonard D S Lutter G Mackay D Maclellan R Marino M Mong B Montero Diez M Morgan P MUller A R Neilson R Odian A Oullivan K Piepke A Pocar A Prescott C Y Pushkin K Rivas A Rollin E Rowson P C Sabourov A Sinclair D Skarpaas K Stekhanov V Strickland V Swift M Twelker K Vuilleumier J L Vuilleumier J M Weber M Wichoski U Wodin J Wright J D Yang L 2012Nuclear Instruments and Methods in Physics Research Section A: Accelerators Spectrometers Detectors and Associated Equipment2012,675,:1
10Pilot study of mutant ras peptide-based vaccine as an adjuvant treatment in pancreatic and colorectal cancers显示文摘Antoun Toubaji Moujahed Achtar Maurizio Provenzano Vincent E. Herrin Robert Behrens Michael Hamilton Sarah Bernstein David Venzon Barry Gause Francesco Marincola Samir N. Khleif 2008Cancer Immunology Immunotherapy2008,,9:1
11Prediction of metabolic rates for manual materials handling jobs 显示文摘Garg A Chaffin D B Herrin G D 1978American Industrial Hygiene Association (S0002-8894)1978,39,8:1
12Times to treatment in transfer patients undergoing primary percutaneous coronary interven- tion in the United States: National Registry of Myocardial Infarction (NRMI) -3/4 analysis显示文摘Nallamothu BK Bates ER Herrin J 2005Circulation2005,111,6:1
13Pregnancy after liver transplantation显示文摘Armenti VT Herrine SK Radomski JS 2000Liver Transpl2000,6,6:1
14Surface wave studies of the Bering Sea and Alaska area显示文摘Jin D J Herrin E 1980Bulletin of the Seismological Society of America1980,70,6:1
15Effect of Door-to-balloon Time on Mortality in Patients with ST-segment Elevation Myocardial Infarction显示文摘McNamara R L Wang Y Herrin J 2006J Am Coll Cardiol2006,47,11:1
16Proton versus intensity modulated radiotherapy for prostate cancer: patterns of care and early toxicity显示文摘Yu JB PR Soulos J Herrin 2013J NatlCancer Inst2013,105,1:1
17Pregnancy atier liver transplantation显示文摘Armenti VT Herrine SK Radomski JS 2000Liver Transpl2000,6,:1
18Improvements in Door-to-Balloon Time in the United States, 2005 to 2010显示文摘Krumholz H M Herrin J Miller L E 2011Circulation2011,124,9:1
19How to calculate safety stocks for highly seasonal products显示文摘Herrin R 2005The Journal of Business Forecasting2005,,:1
20Antibody responses of variable lymphocyte receptors in the lamprey显示文摘ALDER M N HERRIN B R SADLONOVA A 2008Nat Immunol2008,9,3:1
返回顶部 每页显示:
共11页 首页 上一页 第1页 下一页 末页 /11 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费